{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:58:41Z","timestamp":1771678721697,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012505","name":"Royal Perth Hospital Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.prp.2021.153724","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T13:01:00Z","timestamp":1638190860000},"page":"153724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Application of multiplex ligation-dependent probe amplification (MLPA) and low pass whole genome sequencing (LP-WGS) to the classification \/ characterisation of low grade glioneuronal tumours"],"prefix":"10.1016","volume":"229","author":[{"given":"Jason","family":"Dyke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie","family":"Calapre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Beasley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elin","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Allcock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Bentel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2021.153724_bib1","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1093\/neuonc\/noz126.000","article-title":"CDKN2A homozygous deletion is a strong adverse prognosis factor in diffuse malignant IDH-mutant gliomas","volume":"21","author":"Appay","year":"2019","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.prp.2021.153724_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11060-005-9037-5","article-title":"Cytoplasmic, but not nuclear, p16 expression may signal poor prognosis in high-grade astrocytomas","volume":"77","author":"Arifin","year":"2006","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.prp.2021.153724_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/nan.12522","article-title":"Review: challenges in the histopathological classification of ganglioglioma and DNT: microscopic agreement studies and a preliminary genotype-phenotype analysis","volume":"45","author":"Blumcke","year":"2019","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.prp.2021.153724_bib4","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/jnen\/61.7.575","article-title":"Gangliogliomas: an intriguing tumor entity associated with focal epilepsies","volume":"61","author":"Bl\u00fcmcke","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.prp.2021.153724_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/bpa.12048","article-title":"Dysembryoplastic neuroepithelial tumors share with pleomorphic xanthoastrocytomas and gangliogliomas BRAF(V600E) mutation and expression","volume":"23","author":"Chapp\u00e9","year":"2013","journal-title":"Brain Pathol."},{"key":"10.1016\/j.prp.2021.153724_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jocn.2017.09.014","article-title":"BRAF V600E mutation is a significant prognosticator of the tumour regrowth rate in brainstem gangliogliomas","volume":"46","author":"Chen","year":"2017","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.prp.2021.153724_bib7","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00401-013-1120-y","article-title":"BRAF(V600E) mutation is a negative prognosticator in pediatric ganglioglioma","volume":"125","author":"Dahiya","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2021.153724_bib8","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.18632\/oncotarget.12881","article-title":"Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors","volume":"8","author":"Fina","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.prp.2021.153724_bib9","doi-asserted-by":"crossref","first-page":"e761","DOI":"10.1016\/j.wneu.2018.09.212","article-title":"CD34 expression in low-grade epilepsy-associated tumors: relationships with clinicopathologic features","volume":"121","author":"Giulioni","year":"2019","journal-title":"World Neurosurg."},{"key":"10.1016\/j.prp.2021.153724_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/jnen\/nlw007","article-title":"Malignant transformation of a dysembryoplastic neuroepithelial tumor (DNET) characterized by genome-wide methylation analysis","volume":"75","author":"Heiland","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.prp.2021.153724_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1750-3639.2008.00122.x","article-title":"Comprehensive characterization of genomic aberrations in gangliogliomas by CGH, array-based CGH and interphase FISH","volume":"18","author":"Hoischen","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.prp.2021.153724_bib12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.eplepsyres.2016.08.028","article-title":"Alterations in BRAF gene, and enhanced mTOR and MAPK signaling in dysembryoplastic neuroepithelial tumors (DNTs)","volume":"127","author":"Kakkar","year":"2016","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.prp.2021.153724_bib13","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00401-013-1100-2","article-title":"Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells","volume":"125","author":"Koelsche","year":"2013","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2021.153724_bib14","first-page":"132","article-title":"Prognostic significance of p16 cellular localization in oropharyngeal squamous cell carcinoma","volume":"46","author":"Lai","year":"2016","journal-title":"Ann. Clin. Lab Sci."},{"key":"10.1016\/j.prp.2021.153724_bib15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/jso.23822","article-title":"BRAF V600E mutations are frequent in dysembryoplastic neuroepithelial tumors and subependymal giant cell astrocytomas","volume":"111","author":"Lee","year":"2015","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.prp.2021.153724_bib16","doi-asserted-by":"crossref","first-page":"5566","DOI":"10.1021\/bi200642e","article-title":"Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer","volume":"50","author":"Li","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.prp.2021.153724_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-016-1646-x","article-title":"Announcing cIMPACT-NOW: the consortium to inform molecular and practical approaches to CNS tumor taxonomy","volume":"133","author":"Louis","year":"2017","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2021.153724_bib18","unstructured":"D.N. Louis, Ohgaki, H., Wiestler, O., Cavanee, W.K., World Health Organization classification of tumours of the central nervous system, 4th edn. (2016)."},{"key":"10.1016\/j.prp.2021.153724_bib19","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1002\/cncr.23965","article-title":"Tumor recurrence and malignant progression of gangliogliomas","volume":"113","author":"Majores","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2021.153724_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11060-019-03138-7","article-title":"Multiplex ligation-dependent probe amplification analysis is useful for detecting a copy number gain of the FGFR1 tyrosine kinase domain in dysembryoplastic neuroepithelial tumors","volume":"143","author":"Matsumura","year":"2019","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.prp.2021.153724_bib21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/humu.21245","article-title":"Predicting functional significance of cancer-associated p16(INK4a) mutations in CDKN2A","volume":"31","author":"McKenzie","year":"2010","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.prp.2021.153724_bib22","unstructured":"R. McLendon, A. Friedman, D. Bigner, E.G. Van Meir, D.J. Brat, G.M. Mastrogianakis, J.J. Olson, T. Mikkelsen, N. Lehman, K. Aldape, W.K. Alfred Yung, O. Bogler, S. VandenBerg, M. Berger, M. Prados, D. Muzny, M. Morgan, S. Scherer, A. Sabo, L. Nazareth, L. Lewis, O. Hall, Y. Zhu, Y. Ren, O. Alvi, J. Yao, A. Hawes, S. Jhangiani, G. Fowler, A. San Lucas, C. Kovar, A. Cree, H. Dinh, J. Santibanez, V. Joshi, M.L. Gonzalez-Garay, C.A. Miller, A. Milosavljevic, L. Donehower, D.A. Wheeler, R.A. Gibbs, K. Cibulskis, C. Sougnez, T. Fennell, S. Mahan, J. Wilkinson, L. Ziaugra, R. Onofrio, T. Bloom, R. Nicol, K. Ardlie, J. Baldwin, S. Gabriel, E.S. Lander, L. Ding, R.S. Fulton, M.D. McLellan, J. Wallis, D.E. Larson, X. Shi, R. Abbott, L. Fulton, K. Chen, D.C. Koboldt, M.C. Wendl, R. Meyer, Y. Tang, L. Lin, J.R. Osborne, B.H. Dunford-Shore, T.L. Miner, K. Delehaunty, C. Markovic, G. Swift, W. Courtney, C. Pohl, S. Abbott, A. Hawkins, S. Leong, C. Haipek, H. Schmidt, M. Wiechert, T. Vickery, S. Scott, D.J. Dooling, A. Chinwalla, G.M. Weinstock, E.R. Mardis, R.K. Wilson, G. Getz, W. Winckler, R.G.W. Verhaak, M.S. Lawrence, M. O\u2032Kelly, J. Robinson, G. Alexe, R. Beroukhim, S. Carter, D. Chiang, J. Gould, S. Gupta, J. Korn, C. Mermel, J. Mesirov, S. Monti, H. Nguyen, M. Parkin, M. Reich, N. Stransky, B.A. Weir, L. Garraway, T. Golub, M. Meyerson, L. Chin, A. Protopopov, J. Zhang, I. Perna, S. Aronson, N. Sathiamoorthy, G. Ren, J. Yao, W.R. Wiedemeyer, H. Kim, S. Won Kong, Y. Xiao, I.S. Kohane, J. Seidman, P.J. Park, R. Kucherlapati, P.W. Laird, L. Cope, J.G. Herman, D.J. Weisenberger, F. Pan, D. Van Den Berg, L. Van Neste, J. Mi Yi, K.E. Schuebel, S.B. Baylin, D.M. Absher, J.Z. Li, A. Southwick, S. Brady, A. Aggarwal, T. Chung, G. Sherlock, J.D. Brooks, R.M. Myers, P.T. Spellman, E. Purdom, L.R. Jakkula, A.V. Lapuk, H. Marr, S. Dorton, Y. Gi Choi, J. Han, A. Ray, V. Wang, S. Durinck, M. Robinson, N.J. Wang, K. Vranizan, V. Peng, E. Van Name, G.V. Fontenay, J. Ngai, J.G. Conboy, B. Parvin, H.S. Feiler, T.P. Speed, J.W. Gray, C. Brennan, N.D. Socci, A. Olshen, B.S. Taylor, A. Lash, N. Schultz, B. Reva, Y. Antipin, A. Stukalov, B. Gross, E. Cerami, W. Qing Wang, L.-X. Qin, V.E. Seshan, L. Villafania, M. Cavatore, L. Borsu, A. Viale, W. Gerald, C. Sander, M. Ladanyi, C.M. Perou, D. Neil Hayes, M.D. Topal, K.A. Hoadley, Y. Qi, S. Balu, Y. Shi, J. Wu, R. Penny, M. Bittner, T. Shelton, E. Lenkiewicz, S. Morris, D. Beasley, S. Sanders, A. Kahn, R. Sfeir, J. Chen, D. Nassau, L. Feng, E. Hickey, J. Zhang, J.N. Weinstein, A. Barker, D.S. Gerhard, J. Vockley, C. Compton, J. Vaught, P. Fielding, M.L. Ferguson, C. Schaefer, S. Madhavan, K.H. Buetow, F. Collins, P. Good, M. Guyer, B. Ozenberger, J. Peterson, E. Thomson, N. The Cancer Genome Atlas Research, S. Tissue source sites: Duke University Medical, U. Emory, H. Henry Ford, M.D.A.C. Center, F. University of California San, M. Genome sequencing centres: Baylor College of, M.I.T. Broad Institute of, Harvard, L. Washington University in St, I. Cancer genome characterization centres: Broad Institute\/Dana-Farber Cancer, I. Harvard Medical School\/Dana-Farber Cancer, C. Johns Hopkins\/University of Southern, U. HudsonAlpha Institute\/Stanford, L. Lawrence Berkeley National, C. Memorial Sloan-Kettering Cancer, C.H. University of North Carolina, R. Biospecimen Core, C. Data Coordinating, I. Project teams: National Cancer, I. National Human Genome Research, Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455 (2008) 1061\u20131068."},{"key":"10.1016\/j.prp.2021.153724_bib23","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jmoldx.2020.06.007","article-title":"High-throughput molecular cancer cell line characterization using digital multiplex ligation-dependent probe amplification for improved standardization of in vitro research","volume":"22","author":"Menezes","year":"2020","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.prp.2021.153724_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40478-018-0551-z","article-title":"The genetic landscape of ganglioglioma","volume":"6","author":"Pekmezci","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.prp.2021.153724_bib25","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/nan.12235","article-title":"Landscape of chromosomal copy number aberrations in gangliogliomas and dysembryoplastic neuroepithelial tumours","volume":"41","author":"Prabowo","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.prp.2021.153724_bib26","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00401-016-1539-z","article-title":"Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology","volume":"131","author":"Qaddoumi","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2021.153724_bib27","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.1073\/pnas.1300252110","article-title":"Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1","volume":"110","author":"Ramkissoon","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.prp.2021.153724_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11060-009-9849-9","article-title":"Clinicopathologic features of recurrent dysembryoplastic neuroepithelial tumor and rare malignant transformation: a report of 5 cases and review of the literature","volume":"94","author":"Ray","year":"2009","journal-title":"J. Neurooncol."},{"key":"10.1016\/j.prp.2021.153724_bib29","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s00401-002-0652-3","article-title":"Expression of the CD34 antigen in pleomorphic xanthoastrocytomas","volume":"105","author":"Reifenberger","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2021.153724_bib30","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00401-016-1549-x","article-title":"Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors","volume":"131","author":"Rivera","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2021.153724_bib31","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1101\/gr.175141.114","article-title":"DNA copy number analysis of fresh and formalin-fixed specimens by shallow whole-genome sequencing with identification and exclusion of problematic regions in the genome assembly","volume":"24","author":"Scheinin","year":"2014","journal-title":"Genome Res."},{"key":"10.1016\/j.prp.2021.153724_bib32","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00401-011-0802-6","article-title":"Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma","volume":"121","author":"Schindler","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2021.153724_bib33","doi-asserted-by":"crossref","unstructured":"S. Serra, R. Chetty, p16, J Clin Pathol 71 (2018) 853\u2013858.","DOI":"10.1136\/jclinpath-2018-205216"},{"key":"10.1016\/j.prp.2021.153724_bib34","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1002\/stem.1661","article-title":"Concise review: evidence for CD34 as a common marker for diverse progenitors","volume":"32","author":"Sidney","year":"2014","journal-title":"Stem Cells"},{"key":"10.1016\/j.prp.2021.153724_bib35","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00401-018-1905-0","article-title":"Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma","volume":"136","author":"Stichel","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2021.153724_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00401-017-1773-z","article-title":"Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours","volume":"135","author":"Stone","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2021.153724_bib37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/bpa.12495","article-title":"Recurrent copy number alterations in low-grade and anaplastic pleomorphic xanthoastrocytoma with and without BRAF V600E mutation","volume":"28","author":"Vaubel","year":"2018","journal-title":"Brain Pathol."},{"key":"10.1016\/j.prp.2021.153724_bib38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00401-019-02078-w","article-title":"Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course","volume":"139","author":"Wefers","year":"2020","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.prp.2021.153724_bib39","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas. The","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2021.153724_bib40","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1097\/PAS.0000000000000160","article-title":"Comparative analysis of atypical spitz tumors with heterozygous versus homozygous 9p21 deletions for clinical outcomes, histomorphology, BRAF mutation, and p16 expression","volume":"38","author":"Yazdan","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153724_bib41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/ng.2611","article-title":"Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas","volume":"45","author":"Zhang","year":"2013","journal-title":"Nat. Genet."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382100385X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S034403382100385X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:50:46Z","timestamp":1759733446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S034403382100385X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":41,"alternative-id":["S034403382100385X"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2021.153724","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of multiplex ligation-dependent probe amplification (MLPA) and low pass whole genome sequencing (LP-WGS) to the classification \/ characterisation of low grade glioneuronal tumours","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2021.153724","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153724"}}